Sun Pharmaceutical Industries Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Sun Pharmaceutical Industries ha aumentado sus beneficios a una tasa media anual de 23.9%, mientras que los beneficios de la industria de Pharmaceuticals han experimentado un crecimiento de 14.8% anual. Los ingresos han ido creciendo a una tasa media de 10.1% al año. La rentabilidad financiera de Sun Pharmaceutical Industries es de 14.1%, y sus márgenes netos son de 18.8%.
Información clave
23.9%
Tasa de crecimiento de los beneficios
23.9%
Tasa de crecimiento del BPA
Crecimiento de la industria Pharmaceuticals | 17.5% |
Tasa de crecimiento de los ingresos | 10.1% |
Rentabilidad financiera | 14.1% |
Margen neto | 18.8% |
Última actualización de beneficios | 31 Dec 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet
Mar 13Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Feb 03Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today
Jan 05Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely
Dec 18Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?
Oct 04Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?
Jul 03We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease
Jun 15Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?
Mar 14Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50
Feb 03These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well
Dec 09Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?
Oct 13These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely
Sep 04Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Aug 05Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Jul 12Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?
Jun 02Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?
Apr 28Are Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Investors Paying Above The Intrinsic Value?
Apr 09Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.00
Feb 02Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Using Too Much Debt?
Feb 02Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?
Jan 19Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Dec 27Sun Pharmaceutical Industries (NSE:SUNPHARMA) Seems To Use Debt Rather Sparingly
Nov 04Here's Why I Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today
Oct 21Calculating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Sep 27Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Sun Pharmaceutical Industries. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 474,446 | 89,063 | 93,681 | 0 |
30 Sep 23 | 463,049 | 85,485 | 90,419 | 0 |
30 Jun 23 | 450,648 | 84,352 | 86,821 | 0 |
31 Mar 23 | 438,857 | 84,736 | 83,549 | 0 |
31 Dec 22 | 424,018 | 42,119 | 80,549 | 0 |
30 Sep 22 | 410,239 | 41,047 | 78,688 | 0 |
30 Jun 22 | 396,975 | 38,894 | 76,169 | 0 |
31 Mar 22 | 386,545 | 32,727 | 73,544 | 0 |
31 Dec 21 | 377,307 | 64,441 | 71,354 | 0 |
30 Sep 21 | 367,044 | 62,378 | 70,049 | 0 |
30 Jun 21 | 356,316 | 60,036 | 68,619 | 0 |
31 Mar 21 | 334,981 | 29,038 | 69,042 | 0 |
31 Dec 20 | 331,601 | 24,095 | 68,729 | 0 |
30 Sep 20 | 324,782 | 14,706 | 67,016 | 0 |
30 Jun 20 | 320,484 | 7,219 | 65,810 | 0 |
31 Mar 20 | 328,375 | 37,649 | 63,986 | 0 |
31 Dec 19 | 318,165 | 40,010 | 64,149 | 0 |
30 Sep 19 | 314,018 | 43,293 | 63,608 | 0 |
30 Jun 19 | 302,161 | 29,956 | 62,101 | 0 |
31 Mar 19 | 290,659 | 26,654 | 61,027 | 0 |
31 Dec 18 | 288,052 | 34,379 | 58,539 | 0 |
30 Sep 18 | 277,182 | 24,380 | 57,316 | 0 |
30 Jun 18 | 275,048 | 35,690 | 54,702 | 0 |
31 Mar 18 | 264,155 | 20,957 | 54,814 | 0 |
31 Dec 17 | 263,811 | 20,763 | 54,007 | 0 |
30 Sep 17 | 276,530 | 31,827 | 52,432 | 0 |
30 Jun 17 | 295,310 | 45,057 | 49,929 | 0 |
31 Mar 17 | 313,081 | 69,644 | 50,285 | 0 |
31 Dec 16 | 319,185 | 73,270 | 49,986 | 0 |
30 Sep 16 | 311,431 | 74,000 | 49,212 | 0 |
30 Jun 16 | 297,512 | 61,937 | 48,012 | 0 |
31 Mar 16 | 281,086 | 45,457 | 49,076 | 0 |
31 Dec 15 | 266,281 | 38,915 | 95,369 | 0 |
30 Sep 15 | 264,670 | 28,702 | 95,000 | 0 |
30 Jun 15 | 276,422 | 38,150 | 45,608 | 0 |
31 Mar 15 | 273,920 | 45,394 | 46,483 | 0 |
31 Dec 14 | 170,765 | 59,141 | 45,586 | 0 |
30 Sep 14 | 170,835 | 60,202 | 45,036 | 0 |
30 Jun 14 | 165,250 | 58,100 | 44,680 | 0 |
31 Mar 14 | 160,804 | 31,415 | 44,040 | 0 |
31 Dec 13 | 150,933 | 26,104 | 35,071 | 0 |
30 Sep 13 | 136,587 | 19,606 | 33,778 | 0 |
30 Jun 13 | 120,629 | 9,364 | 16,868 | 0 |
Ingresos de calidad: SUNPHARMA tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (18.8%) de SUNPHARMA son superiores a los del año pasado (9.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lSUNPHARMA han crecido significativamente en un 23.9% al año.
Acelerando crecimiento: El crecimiento de los beneficios de SUNPHARMA en el último año (111.5%) supera su media de 5 años (23.9% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de SUNPHARMA en el último año (111.5%) superó al de la industria Pharmaceuticals 23.8%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de SUNPHARMA (14.1%) se considera baja.